JP2023535027A5 - - Google Patents
Info
- Publication number
- JP2023535027A5 JP2023535027A5 JP2023504298A JP2023504298A JP2023535027A5 JP 2023535027 A5 JP2023535027 A5 JP 2023535027A5 JP 2023504298 A JP2023504298 A JP 2023504298A JP 2023504298 A JP2023504298 A JP 2023504298A JP 2023535027 A5 JP2023535027 A5 JP 2023535027A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- cycloalkyl
- heterocycle
- substituted
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026020484A JP2026097841A (ja) | 2020-07-21 | 2026-02-10 | ピルビン酸キナーゼを活性化するための組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063054478P | 2020-07-21 | 2020-07-21 | |
| US63/054,478 | 2020-07-21 | ||
| PCT/US2021/042489 WO2022020424A1 (en) | 2020-07-21 | 2021-07-21 | Compositions and methods for activating pyruvate kinase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026020484A Division JP2026097841A (ja) | 2020-07-21 | 2026-02-10 | ピルビン酸キナーゼを活性化するための組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535027A JP2023535027A (ja) | 2023-08-15 |
| JP2023535027A5 true JP2023535027A5 (cg-RX-API-DMAC7.html) | 2024-07-03 |
Family
ID=79728915
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504298A Pending JP2023535027A (ja) | 2020-07-21 | 2021-07-21 | ピルビン酸キナーゼを活性化するための組成物及び方法 |
| JP2026020484A Pending JP2026097841A (ja) | 2020-07-21 | 2026-02-10 | ピルビン酸キナーゼを活性化するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026020484A Pending JP2026097841A (ja) | 2020-07-21 | 2026-02-10 | ピルビン酸キナーゼを活性化するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230374017A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4185293A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023535027A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116249531A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021311597B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3183980A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022020424A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12233063B2 (en) | 2017-10-20 | 2025-02-25 | The Regents Of The University Of Michigan | Compositions and methods for treating eye disorders |
| WO2023052783A1 (en) * | 2021-09-30 | 2023-04-06 | Sitryx Therapeutics Limited | Novel compounds |
| CN118434720A (zh) | 2021-12-22 | 2024-08-02 | 西特瑞治疗有限公司 | 作为丙酮酸激酶调节剂的酞嗪衍生物 |
| WO2023211999A1 (en) * | 2022-04-29 | 2023-11-02 | The Regents Of The University Of Michigan | Compositions and methods for treating eye disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100137320A1 (en) * | 2008-02-29 | 2010-06-03 | Schering Corporation | Gamma secretase modulators |
| US8563580B2 (en) * | 2008-09-23 | 2013-10-22 | Georgetown University | Flavivirus inhibitors and methods for their use |
| ES2620634T3 (es) * | 2008-10-09 | 2017-06-29 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Activadores de piruvato quinasa humana |
| EP2968323A4 (en) * | 2013-03-13 | 2016-12-14 | Flatley Discovery Lab | PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS |
| EP3668513B1 (en) * | 2017-08-15 | 2021-11-10 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in treating blood disorders |
| US12233063B2 (en) * | 2017-10-20 | 2025-02-25 | The Regents Of The University Of Michigan | Compositions and methods for treating eye disorders |
| US20220127267A1 (en) * | 2019-02-13 | 2022-04-28 | Agios Pharmaceuticals, Inc. | Thieno[3,2-b] pyrrole[3,2-d]pyridazinone derivatives and their use as pkm2 derivatives for the treatment of cancer, obesity and diabetes related disorders |
-
2021
- 2021-07-21 CA CA3183980A patent/CA3183980A1/en active Pending
- 2021-07-21 US US18/017,108 patent/US20230374017A1/en active Pending
- 2021-07-21 AU AU2021311597A patent/AU2021311597B2/en active Active
- 2021-07-21 JP JP2023504298A patent/JP2023535027A/ja active Pending
- 2021-07-21 CN CN202180058558.3A patent/CN116249531A/zh active Pending
- 2021-07-21 WO PCT/US2021/042489 patent/WO2022020424A1/en not_active Ceased
- 2021-07-21 EP EP21846999.7A patent/EP4185293A4/en active Pending
-
2026
- 2026-02-10 JP JP2026020484A patent/JP2026097841A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023506410A5 (cg-RX-API-DMAC7.html) | ||
| JP2019520417A5 (cg-RX-API-DMAC7.html) | ||
| TW536401B (en) | A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain | |
| JP2005527622A5 (cg-RX-API-DMAC7.html) | ||
| JP6087367B2 (ja) | 三環式化合物、それらを含む組成物およびそれらの使用 | |
| JP2021535112A5 (cg-RX-API-DMAC7.html) | ||
| KR20190133047A (ko) | Mor 작용제 및 kor 작용제를 함유하는 약학적 조성물, 및 그의 용도 | |
| JP2018048183A (ja) | 持続時間が超短期、短期、または中期の非対称性逆転可能神経筋遮断物質 | |
| CA3006189A1 (en) | Comt inhibiting methods and compositions | |
| JP2023513797A5 (cg-RX-API-DMAC7.html) | ||
| JP2016525104A5 (cg-RX-API-DMAC7.html) | ||
| MX2008011965A (es) | Composicion de combinacion farmaceutica comprendiendo al menos un inhibidor de pkc y al menos un inhibidor de jak cinasa para tratar desordenes autoinmunes. | |
| CN106572989A (zh) | 用于治疗骨髓增生异常综合征的蛋白磷酸酶2a抑制剂 | |
| JP2019502686A5 (cg-RX-API-DMAC7.html) | ||
| JP2016074699A (ja) | プロセス | |
| JP2024522183A5 (cg-RX-API-DMAC7.html) | ||
| JP2024504927A5 (cg-RX-API-DMAC7.html) | ||
| JP2024511057A5 (cg-RX-API-DMAC7.html) | ||
| CA2608463C (en) | Compounds, compositions containing such compounds, and methods of treatment of metastatic melanoma and other cancers | |
| IL321852A (en) | Medication bracelets for the treatment of eye disorders | |
| CN114681458B (zh) | 治疗多发性硬化症的方法 | |
| JP2007513948A5 (cg-RX-API-DMAC7.html) | ||
| JP2005525377A (ja) | デスメチルセレジリンの投与による末梢神経障害の予防および処置のための方法 | |
| RU2007111704A (ru) | 4[(2,4-дихлоро-5-метоксифенил)амино]-6-алкокси-7-этинил-3-хинолинкарбонитрилы для лечения ишемического поражения | |
| CN102272126A (zh) | 光学纯喹唑啉类化合物 |